Investigation of the effects of camel milk on children with asthma

Investigation of the effects of camel milk on spirometric parameters of children aged over 6 years with asthma

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170813035653N2

Enrollment

Registered

2018-12-09

Start date

2018-02-07

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma in children. Asthma

Interventions

Intervention 1: Control group: Patients will receive medication treatment (inhaled corticosteroids, montelukast and long-acting beta-agonists) according to the standard protocol. Intervention 2: Inter

Eligibility

Sex/Gender

All

Age

6 Years to 18 Years

Inclusion criteria

Inclusion criteria: Children aged over 6 years with asthma who are classified as ''not well control'' according to Nelson's book Forced Expiratory Volume in First Second (FEV1) is 60-80% and Forced Expiratory Volume in First Second/Forced Vital Capacity (FEV1/FVC) is 75-80% in spirometry. Patients are under controller therapy Patients are not under asthma attack

Exclusion criteria

Exclusion criteria: Asthma attack during the investigation period Unwillingness to continue participation in the study Creation of any sensitivity and intolerance to camel milk during the course

Design outcomes

Primary

Measure	Time frame
Percentage of people whose Forced Expiratory Volume in First Second (FEV1) exceeds 80%. Timepoint: At the beginning of the study (before the intervention) and two months after beginning drug use (after the intervention). Method of measurement: spirometer device.;Percentage of people whose Forced Expiratory Volume in First Second/Forced Vital Capacity (FEV1/FVC) exceeds 80%. Timepoint: At the beginning of the study (before the intervention) and two months after beginning drug use (after the intervention). Method of measurement: spirometer device.	—

Measure

Time frame

Percentage of people whose Forced Expiratory Volume in First Second (FEV1) exceeds 80%. Timepoint: At the beginning of the study (before the intervention) and two months after beginning drug use (after the intervention). Method of measurement: spirometer device.;Percentage of people whose Forced Expiratory Volume in First Second/Forced Vital Capacity (FEV1/FVC) exceeds 80%. Timepoint: At the beginning of the study (before the intervention) and two months after beginning drug use (after the intervention). Method of measurement: spirometer device.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr seyed Javad Sayedi

Mashhad University of Medical Sciences

SayediJ@mums.ac.ir+98 51 3727 3943

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026